Healthcare and Distribution Services - Audon Trap & Partners
Healthcare and Distribution Services - Audon Trap & Partners
Healthcare and Distribution Services - Audon Trap & Partners
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Diagnostics<br />
DDD Diagnostic Advisor to seller<br />
DDD Diagnostic develops, manufactures <strong>and</strong> markets gamma cameras for nuclear<br />
medicine. The cameras are used for scanning heart, kidney <strong>and</strong> cancer patients.<br />
The cameras are among other places used by privately practicing cardiologists <strong>and</strong><br />
hospitals in connection with the diagnosis of cardiopulmonary diseases.<br />
The gamma cameras are primarily marketed in the USA through major companies<br />
that distribute the products under their own br<strong>and</strong>.<br />
<strong>Audon</strong> <strong>Partners</strong> assisted DDD Diagnostic in the raise of equity capital from financial<br />
investors Dansk Erhvervsinvestering <strong>and</strong> Dansk Innovationsinvestering.<br />
Gamma Biologicals, Inc. Immucor, Inc. Advisor to buyer<br />
Immucor, Inc. (NASDAQ: BLUD) is a leading supplier of diagnostic reagents <strong>and</strong><br />
automated instrumentation to ensure the safety of blood transfusions. Immucor<br />
retained TM Capital as financial advisor to assist in an acquisition program which<br />
would build the company's position in the transfusion diagnostics marketplace.<br />
TM Capital assisted Immucor in negotiating the acquisition of Gamma Biologicals,<br />
Inc. (AMEX: GBL) for $30 million via a cash tender offer for which TM Capital also<br />
served as dealer manager.<br />
Since completing this acquisition, Immucor's superior performance has generated an<br />
increase in its market capitalization from $75 million to over $2 billion.<br />
Kainos Laboratories, Inc. Immucor, Inc. Advisor to buyer<br />
Immucor, Inc. (NASDAQ: BLUD) is a leading supplier of diagnostic reagents <strong>and</strong><br />
automated instrumentation to ensure the safety of blood transfusions. Immucor has<br />
established direct distribution in many global markets, but its Japanese distribution<br />
rights were exclusively held by Kainos Laboratories, Inc., a publicly traded Japanese<br />
company.<br />
Immucor retained TM Capital to structure <strong>and</strong> negotiate the acquisition of the blood<br />
bank distribution division of Kainos <strong>and</strong> achieve direct distribution in Japan. TM<br />
Capital assisted Immucor in the formation of a joint venture with Kainos providing<br />
Immucor with immediate 51% ownership of its Japanese distribution company <strong>and</strong><br />
eventual 100% ownership.<br />
M&A International Inc.<br />
member firm:<br />
<strong>Audon</strong> <strong>Partners</strong><br />
TM Capital Corp.<br />
TM Capital Corp.<br />
17
Change language